OnKure Therapeutics, Inc. financial statements
OnKure Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 59.52M | 10-K |
| Cash and equivalents | USD 59.05M | 10-Q |
| Total debt | USD 549K | EODHD |
OnKure Therapeutics, Inc. financials on 6ix · OnKure Therapeutics, Inc. on 6ix